Genomic Valley Biotech Ltd - 539206 - Shareholding for the Period Ended September 30, 2020
Genomic Valley Biotech Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that Mrs. Monisha Meghna (Membership No. A41747) has tendered his resignation from the post of Company Secretary and Compliance Officer of the Company with effect from 07.10.2020 by submitting his resignation letter dated 07.10.2020 to the Board of Directors of the Company. Genomic Valley Biotech Ltd - 539206 - Closure of Trading Window
Pursuant to the Code of Conduct for Prevention of Insider Trading of the Company under SEBI(Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform you that the trading window for the purpose of trading in the securities of the Company by its Designated persons shall remain closed from October 01, 2020 till 48 (Forty Eight) hours after the conclusion of the Meeting of the Board of Directors of the Company to be held to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2020. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Advertisements published for the Un-Audited Financial Results for the quarter and three months ended June 30, 2020 in the newspapers, Financial Express (English Edition) and Jansatta (Hindi Edition) on 17th September, 2020. Genomic Valley Biotech Ltd - 539206 - Intimation Of Re-Constitution Of The Composition Of Committees Of The Company
As Mr. Rajesh Kumar Saxena has been resigned from the post of Non-Executive Independent Director of the Company with effect from 15.09.2020 who was the member of Audit Committee, Nomination & Remuneration Committee, Risk Management Committee and Stakeholders Relationship Committee of the Company, therefore, there is need to appoint Mr. Satendra Kumar Goyal, Non-Executive Independent Director as Member of Audit Committee, Nomination & Remuneration Committee, Risk Management Committee and Stakeholders Relationship Committee of the Company in place of Mr. Rajesh Kumar Saxena to complete the Composition of the Committee. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that Mr. Rajesh Kumar Saxena has tendered his resignation from the post of Non-Executive Independent Director of the Company with effect from September 15, 2020 by submitting his resignation letter dated September 14, 2020 to the Board of Directors of the Company. Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that Mr. Rajesh Kumar Saxena has tendered his resignation from the post of Non-Executive Independent Director of the Company with effect from September 15, 2020 by submitting his resignation letter dated September 14, 2020 to the Board of Directors of the Company. Genomic Valley Biotech Ltd - 539206 - Un-Audited Financial Results For The Quarter And Three Months Ended 30Th June, 2020
Intimation and disclosure under Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Un-Audited Financial Results and Limited Review Report for the quarter and three months ended 30.06.2020 Genomic Valley Biotech Ltd - 539206 - Submission Of Outcomes Of Board Meeting And Un-Audited Financial Results For The Quarter And Three Months Ended 30Th June, 2020
Intimation and disclosure under Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Un-Audited Financial Results and Limited Review Report for the quarter and three months ended 30.06.2020 Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Advertisements published for the Notice of Board Meeting to be held on 15th September, 2020, inter-alia, to consider and approve the Un-Audited Financial Results for the quarter and three months ended 30th June, 2020, in the newspapers, Financial Express (English Edition) and Haribhoomi (Hindi Edition) on 08th September, 2020.